
### [NCIT:C7643](http://purl.obolibrary.org/obo/NCIT_C7643)
**Label:** Alkylating Agent-Related Myelodysplastic Syndrome

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.46%
- [NCIT:C42606](http://purl.obolibrary.org/obo/NCIT_C42606) (Chemotherapeutic Agent Toxicity) 51.61%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39751](http://purl.obolibrary.org/obo/NCIT_C39751) (Glioblastoma, IDH-Mutant))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39748](http://purl.obolibrary.org/obo/NCIT_C39748) (Lymphoblast-Like Neoplastic B-Lymphocyte))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39741](http://purl.obolibrary.org/obo/NCIT_C39741) (Retroperitoneal Inflammatory Myofibroblastic Tumor))) 44.05%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor))) 44.05%


